The U.S. Food and Drug Administration has approved the first clinical trial in the United States to test a bone marrow stem cell therapy for severe heart failure. The trial, due to begin within the next week or so, will be led by Emerson C. Perin and his colleagues at the Texas Heart Institute in Houston, Texas.
